CPD: ‘Quality, safety and sourcing in unlicensed medicines’

With the NHS under pressure, patient safety is an ongoing challenge faced by hospitals, with the latest CQC report highlighting that four in five health trusts need to improve patient safety1 At UL Medicines, we understand the key roles that pharmacists and pharmacy technicians play in supporting quality care in hospitals. We are committed to continuously driving professional standards by providing ongoing access to educational CPD tools in our pledge to support the NHS.

Working with APTUK (Association of Pharmacy Technicians UK), we have developed our first CPD module, ‘Quality safety and sourcing in unlicensed medicines,’ focusing on guidance around managing the risks that are commonly associated with sourcing unlicensed medicines. We are working to inform, educate and support healthcare professionals and help manage risk in an area in which it is difficult to access accurate, impartial information.

At the end of the course…

  • You will understand what an unlicensed medicine is, and when it should be prescribed
  • You will be able to understand the hierarchy of risk in prescribing and how to safeguard patients
  • You will know what questions to ask to ensure suppliers are best placed to guarantee quality and patient safety
  • You will be able to ensure your product has the correct supporting documentation

Take the Course Now!

To start the course, please complete the form on the right, after which you will be directed to the learning module.

1 NHS standing on burning platform, inspectors warn March 2017 BBC http://www.bbc.co.uk/news/uk-england-39071485

* indicates mandatory field

Terms of usage

UL Medicines Limited and our Group companies * would like to ensure that we only send you information that is relevant and appropriate to you. Please complete the below form and select the updates and alerts you are interested in receiving.

  • I request that UL Medicines Limited keep me updated on product availability, technical details and pricing of individual imported unlicensed medicines and UK specials
  • I also acknowledge that these are unlicensed medicines and there is no marketing authorisation for these products in the UK
  • I acknowledge that UL Medicines are making no claims as to the safety and efficacy of these products.

* Information about our Group companies can be found at www.quantumpharmagroup.co.uk